Curasight to present at HC Andersen Capital and at HC Andersen Life Science seminar
Copenhagen, Denmark, 25 August 2023 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces that CEO Ulrich Krasilnikoff and CSO professor Andreas Kjær will present the company’s Interim Report Q2 2023 at HC Andersen Capital 30 August and the clinical progress at HC Andersen Capital Life Science seminar, 31 August 2023.The presentations will include an update on the business progress made by the company during the first half of 2023 and look ahead at the coming news flow expected in rest of 2023. Management will give an overall update on the company’s pipeline based